logo-loader
ASX:BIT

Biotron Ltd

Receive alerts
Market:
ASX
Market Cap:
$70.19 m
Price
0.10 AUD
Change
12.36%
52 weeks high
0.19
52 weeks low
0.05

In brief

Biotron Ltd (ASX:BIT) is a clinical-stage biotech company developing and commercialising a novel small molecule approach that has the potential to treat a number of serious viral diseases.

The company's lead compound, BIT225, is in Phase 2 development for the treatment of HIV-1 and hepatitis C.